Publications by authors named "Birgit Olsson"

Claim this Profile
O
Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis.
Yang-Mei Shen, Gunnar Arbman, Birgit Olsson, Xiao-Feng Sun

Int J Biol Markers· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Livin expression is an independent factor in rectal cancer patients with or without preoperative radiotherapy.
Zhen-Yu Ding, Hong Zhang, Gunnar Adell, Birgit Olsson, Xiao-Feng Sun

Radiat Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.
Zhen-Yu Ding, Gui-Hong Liu, Birgit Olsson, Xiao-Feng Sun

Tumour Biol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
Yang-Mei Shen, Gunnar Arbman, Per Sandström, Per Gullstrand, Yu-Quan Wei, Birgit Olsson

Oncol Rep· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
Elin Karlsson, Marie Ahnström Waltersson, Josefine Bostner, Gizeh Pérez-Tenorio, Birgit Olsson

Genes Chromosomes Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer.
Gizeh Pérez-Tenorio, Elin Karlsson, Marie Ahnström Waltersson, Birgit Olsson, Birgitta Holmlund

Breast Cancer Res Treat· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer.
Cecilia Gunnarsson, Piiha-Lotta Jerevall, Karl Hammar, Birgit Olsson, Bo Nordenskjöld

Breast Cancer Res Treat· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer.
Gizeh Pérez-Tenorio, Liza Alkhori, Birgit Olsson, Marie Ahnström Waltersson, Bo Nordenskjöld

Clin Cancer Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients.
Marie Stenmark Askmalm, John Carstensen, Bo Nordenskjöld, Birgit Olsson, Lars Erik Rutqvist

Acta Oncol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Akt kinases in breast cancer and the results of adjuvant therapy.
Olle Stål, Gizeh Pérez-Tenorio, Linda Akerberg, Birgit Olsson, Bo Nordenskjöld

Breast Cancer Res· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplification of HSD17B1 and ERBB2 in primary breast cancer.
Cecilia Gunnarsson, Marie Ahnström, Kristina Kirschner, Birgit Olsson, Bo Nordenskjöld

Oncogene· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis